Alessio Barilli

Title: Alessio Barilli: Innovator in Pharmaceutical Chemistry

Introduction

Alessio Barilli is a notable inventor based in Parma, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific biological pathways. His work is characterized by a focus on innovative solutions for medical challenges.

Latest Patents

Alessio Barilli holds a patent for "Pyridazinyl amino derivatives as ALK5 inhibitors." This invention relates to a compound of general formula (I) that inhibits the transforming growth factor-β (TGF-β) type I receptor (ALK5). The patent outlines methods for preparing these compounds, pharmaceutical compositions containing them, and their therapeutic uses. The compounds may be beneficial in treating diseases or conditions associated with dysregulation of the ALK5 signaling pathway in mammals. He has 1 patent to his name.

Career Highlights

Alessio Barilli is currently employed at Chiesi Farmaceutici S.p.A., a company known for its commitment to research and development in the pharmaceutical sector. His role involves leveraging his expertise to advance the company's innovative projects and contribute to the development of new therapeutic solutions.

Collaborations

Throughout his career, Alessio has collaborated with talented professionals, including Matteo Biagetti and Paolo Ronchi. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Alessio Barilli exemplifies the spirit of innovation in pharmaceutical chemistry. His contributions, particularly in the area of ALK5 inhibitors, highlight the importance of research and collaboration in developing effective medical treatments. His work continues to inspire future advancements in the field.